Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Docetaxel polymer nano injection and preparation method thereof

A technology of docetaxel and polymers, which is applied in the field of medicine, can solve the problems of limited coating stability, easy to burst into the whole body, and too fast release, so as to avoid systemic toxic and side effects, improve the therapeutic effect, and enhance the inhibitory effect. Effect

Active Publication Date: 2021-02-02
四川美大康佳乐药业有限公司
View PDF5 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] But the water solubility of docetaxel is poor, almost insoluble in water, prior art adopts Tween80 solubilization, ethanol solubilization to make pharmaceutical preparation; Because the existence of Tween80 makes this preparation in clinical use process can cause as allergic reaction, Severe adverse reactions such as neurotoxicity; and after docetaxel enters the body, the distribution is non-selective and reaches various tissues and organs throughout the body, thereby causing systemic toxic and side effects, and easily causing toxicity to the nervous system and immune system, especially neutropenia Such as immune system toxicity, which greatly harms the physical and mental health of patients, which limits its clinical application; in addition, the stability of docetaxel is limited, and it must be used within 4 hours after clinical preparation, which limits the administration of docetaxel
[0004] At present, the existing technology solves the problem of poor water solubility of docetaxel by coating water-soluble polymer micelles on the surface of docetaxel, but its coating stability is still limited, and it will also be released suddenly when placed It is not highly resistant, it is inconvenient to apply, and it is easy to release suddenly after entering the body, which will bring systemic toxic and side effects; in addition, it is released too quickly after entering the body, and the therapeutic effect on tumor cells is not good.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Docetaxel polymer nano injection and preparation method thereof
  • Docetaxel polymer nano injection and preparation method thereof
  • Docetaxel polymer nano injection and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0037] The present embodiment provides a docetaxel polymer nano-injection, comprising the following components: modified docetaxel, chlorin and PCL-acylamide-PEG; the modified docetaxel consists of shell The cross-linked polymer is coated and modified; the modified docetaxel and chlorin are connected through an orthoester bond; the PCL-acylamide-PEG is coated on the outside of the chlorin.

[0038] This embodiment also provides a preparation method of docetaxel polymer nano-injection, comprising the following steps:

[0039] S1: pre-prepared PPhe-PLys-PEG shell cross-linked polymer;

[0040] S2: Dissolving docetaxel and PPhe-PLys-PEG shell cross-linked polymer in a methanol solution at a mass ratio of 1:2.5, heating at 30°C for 11 hours, and then evaporating the solvent to prepare modified docetaxel;

[0041] S3: Dissolve the modified docetaxel and chlorin in THF under argon at a mass ratio of 1:1, add 10 drops of toluenesulfonic acid dropwise, stir and react at 35°C for 4 ho...

Embodiment 2

[0044]The present embodiment provides a docetaxel polymer nano-injection, comprising the following components: modified docetaxel, chlorin and PCL-acylamide-PEG; the modified docetaxel consists of shell The cross-linked polymer is coated and modified; the modified docetaxel and chlorin are connected through an orthoester bond; the PCL-acylamide-PEG is coated on the outside of the chlorin.

[0045] This embodiment also provides a preparation method of docetaxel polymer nano-injection, comprising the following steps:

[0046] S1: pre-prepared PPhe-PLys-PEG shell cross-linked polymer;

[0047] S2: Dissolving docetaxel and PPhe-PLys-PEG shell cross-linked polymer in a methanol solution at a mass ratio of 1:3, heating at 35°C for 10 hours, and then evaporating the solvent to prepare modified docetaxel;

[0048] S3: Dissolve the modified docetaxel and chlorin in THF under argon at a mass ratio of 1:2, add 20 drops of toluenesulfonic acid dropwise, stir and react at 45°C for 3 hours...

Embodiment 3

[0051] The present embodiment provides a docetaxel polymer nano-injection, comprising the following components: modified docetaxel, chlorin and PCL-acylamide-PEG; the modified docetaxel consists of shell The cross-linked polymer is coated and modified; the modified docetaxel and chlorin are connected through an orthoester bond; the PCL-acylamide-PEG is coated on the outside of the chlorin.

[0052] This embodiment also provides a preparation method of docetaxel polymer nano-injection, comprising the following steps:

[0053] S1: pre-prepared PPhe-PLys-PEG shell cross-linked polymer;

[0054] S2: Dissolving docetaxel and PPhe-PLys-PEG shell cross-linked polymer in a methanol solution at a mass ratio of 1:2, heating at 25°C for 12 hours, and then evaporating the solvent to prepare modified docetaxel;

[0055] S3: Dissolve the modified docetaxel and chlorin in THF under argon at a mass ratio of 1:1.5, add 15 drops of toluenesulfonic acid dropwise, stir and react at 40°C for 3 ho...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
particle sizeaaaaaaaaaa
Login to View More

Abstract

The invention provides a docetaxel polymer nano injection. The docetaxel polymer nano injection comprises the following components: modified docetaxel, a photosensitizer and a PH sensitive block, wherein the modified docetaxel is coated and modified by a shell cross-linked polymer; the modified docetaxel is connected with the photosensitizer through an acid sensitive bond; and the PH sensitive block coats the photosensitizer. The invention further provides a preparation method of the docetaxel polymer nano injection. According to the docetaxel polymer nano injection, the docetaxel has high stability while having high water solubility, is not liable to cause toxic and side effects of the whole body due to burst release, and can be slowly released; and meanwhile, chemotherapy and phototherapy are combined for treatment, so that the treatment effect on tumor cells can be effectively improved.

Description

technical field [0001] The invention relates to the technical field of medicine, in particular to a docetaxel polymer nano-injection and a preparation method thereof. Background technique [0002] Taxanes play an important role in the treatment of various solid tumors; docetaxel, a second-generation semi-synthetic taxane derivative, is about twice as effective as paclitaxel in participating in microtubule depolymerization, and can inhibit Cell division is mostly used to treat tumor diseases such as advanced breast cancer and non-small cell lung cancer. [0003] But the water solubility of docetaxel is poor, almost insoluble in water, prior art adopts Tween80 solubilization, ethanol solubilization to make pharmaceutical preparation; Because the existence of Tween80 makes this preparation in clinical use process can cause as allergic reaction, Severe adverse reactions such as neurotoxicity; and after docetaxel enters the body, the distribution is non-selective and reaches var...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K9/08A61K31/337A61K41/00A61K9/50A61K47/34A61K47/55A61P35/00
CPCA61K31/337A61K47/55A61K41/0071A61K9/0019A61K9/08A61P35/00A61K9/5073A61K9/5031A61K2300/00
Inventor 张祝君秦方云刘晓娟杨丹洲
Owner 四川美大康佳乐药业有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products